CapsoVision (CV) Cash from Investing Activities (2024 - 2025)

CapsoVision's (CV) quarterly Cash from Investing Activities came in at -$8000.0 in Q4 2025, up 33.33% quarter-over-quarter from -$12000.0 in Q3 2025.

CapsoVision (CV) Cash from Investing Activities (2024 - 2025) Analysis & Trends

CapsoVision has disclosed Cash from Investing Activities across 2 years of filings, most recently posting -$8000.0 for Q4 2025.

Cash from Investing Activities for Q4 2025 came in at -$8000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$24000.0 (changed N/A YoY), and the FY2025 annual result was -$90000.0, up 41.18% from the prior year.
Cash from Investing Activities came in at -$8000.0 for Q4 2025 at CapsoVision, up from -$12000.0 in the prior quarter.
In the past five years, Cash from Investing Activities ranged from a high of -$4000.0 in Q3 2024 to a low of -$12000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Activities (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	-20.32 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	-185.00 Mn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	-816.00 Mn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	-591.00 Mn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	-92.80 Mn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	-2.50 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-475.32 Mn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	-298.50 Mn
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	-217.20 Mn
10	CapsoVision	176.55 Mn	166.44 Mn	1.95 Mn	-8,000.00

Download Data